FDA Grants Breakthrough Therapy Designation to Daiichi Sankyo’s DS-8201 for HER2-Positive Metastatic Breast Cancer
Author: Barbara Jacoby / Source: Let Life Happen From: PR Newswire — Breakthrough...
WHAT'S UP IN
ERBB2
Finding the Right Place for Dual HER2 Blockade in Breast Cancer and Beyond
Source: OncLive Although drugs that target HER2 have transformed the prognosis for many patients...
